Viewing data from:

TOLTERODINE TARTRATE

ANDA

TOLTERODINE TARTRATE | A077006 | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: DETROL(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Tolterodine Tartrate (2023)

Total Spending

$14.4M

Total Claims

149,460

Beneficiaries

39,625

Avg Cost/Unit

$1.14

Spending Trend

$23.7M(2019)→$20.5M(2020)→$17.7M(2021)→$16.1M(2022)→$14.4M(2023)

YoY Change:-16.5%

5yr CAGR:-7.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain14 active DMFs7 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVTOLTERODINE TARTRATE

DMF 169952003

CIPLA LTDTOLTERODINE TARTRATE USP

DMF 170182003

DR REDDYS LABORATORIES LTDTOLTERODINE TARTRATE

DMF 177362004

INTERQUIM SATOLTERODINE TARTRATE

DMF 195992006

AMINO CHEMICALS LTDTOLTERODINE TARTRATE

DMF 200932006

HOLIDAY LABS MEXICO SA DE CVTOLTERODINE TARTRATE

DMF 200962006

ERREGIERRE SPATOLTERODINE TARTRATE

DMF 204832007

HETERO DRUGS LTDTOLTERODINE TARTRATE

DMF 223812009

ORCHID PHARMA LTDTOLTERODINE TARTRATE (NON-STERILE BULK API)

DMF 236292010

MACLEODS PHARMACEUTICALS LTDTOLTERODINE TARTRATE USP

DMF 238432010

UNICHEM LABORATORIES LTDTOLTERODINE TARTRATE USP

DMF 251552011

EMCURE PHARMACEUTICALS LTDTOLTERODINE TARTRATE

DMF 290112015

ALKEM LABORATORIES LTDTOLTERODINE TARTRATE USP

DMF 309942016

MAITHRI LABORATORIES PRIVATE LTDTOLTERODINE TARTRATE USP

DMF 347192020

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveTOLTERODINE TARTRATE

DMF 170262003

LUPIN LTDInactiveTOLTERODINE TARTRATE USP

DMF 193242006

INTERQUIM SAInactiveTOLTERODINE TARTRATE MICRONIZED

DMF 196252006

NATCO PHARMA LTDInactiveTolterodine Tartrate

DMF 211642007

LEK PHARMACEUTICALS DDInactiveTOLTERODINE TARTRATE

DMF 211842007

APOTEX PHARMACHEM INDIA PVT LTDInactiveTOLTERODINE TARTRATE

DMF 229962009

ZAKLADY FARMACEUTYCZNE POLPHARMA SAInactiveTOLTERODINE TARTRATE

DMF 243452010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 23, 2015

No patent or exclusivity listings for this strength.

#002 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 23, 2015